HMGB1 and serum lipopolysaccharide activity: Wang showed that treatment of FeTPPS (a small molecule selectively inhibits HMGB1- mediated caspase-11 activation) attenuates HMGB1- and caspase-11-mediated immune responses, organ damage, and lethality in endotoxemia and bacterial sepsis [24].